ConductScience.org, home

Paper2467792

Serotonin metabolism and age-related effects of antihypertensive therapy with ketanserin.

Amstein R and 4 others. Drugs, 1988. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Serotonin metabolism and age-related effects of antihypertensive therapy with ketanserin. Papers, record 2467792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2467792

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Serotonin metabolism and age-related effects of antihypertensive therapy with ketanserin.
PubMed
Journal
Drugs
PubMed
Year
1988
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.83
iCite
Revised in PubMed
2026-10-11
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Amstein RR
2Fetkovska NN
3Ferracin FF
4Pletscher AA
5Bühler FRF R

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypertensionMajor topic
KetanserinMajor topic
SerotoninMajor topic
Adult
Age Factors
Aged
Female
Humans
Hydroxyindoleacetic Acid
Male
Middle Aged
Platelet Aggregation

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12936531Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries.Circulation1986https://conductscience.org/library/papers/2936531PubMed
23545116Comparison of ketanserin and metoprolol in the treatment of essential hypertension.Arch Intern Med1987https://conductscience.org/library/papers/3545116PubMed
32412052Blood pressure, 5-OH indoleacetic acid, and vanilmandelic acid excretion and blood platelet aggregation in hypertensive patients treated with ketanserin.J Cardiovasc Pharmacol1985https://conductscience.org/library/papers/2412052PubMed
43657383Steady-state model for plasma free and platelet serotonin in man.Life Sci1987https://conductscience.org/library/papers/3657383PubMed
53415805Effects of ketanserin on blood pressure and platelet aggregation in elderly men with mild hypertension.Am J Hypertens1988https://conductscience.org/library/papers/3415805PubMed
66215842Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.Agents Actions1982https://conductscience.org/library/papers/6215842PubMed
72939211Serotonin and the blood vessel wall.J Hypertens Suppl1986https://conductscience.org/library/papers/2939211PubMed
87298125Effect of age and spontaneous hypertension on the tachyphylaxis to 5-hydroxytryptamine and angiotensin II in the isolated rat kidney.Hypertension1981https://conductscience.org/library/papers/7298125PubMed
92931964The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases.Agents Actions1985https://conductscience.org/library/papers/2931964PubMed
102446058Antihypertensive efficacy of ketanserin alone or in combination with a beta-blocker or a diuretic: the Swiss Ketanserin Study.J Cardiovasc Pharmacol1987https://conductscience.org/library/papers/2446058PubMed
1124674035HT-kinetics and sensitivity of human blood platelets: variations with age, gender and platelet number.Thromb Haemost1988https://conductscience.org/library/papers/2467403PubMed
123821925The direct and amplifying effects of serotonin are increased with age in the isolated perfused kidney of Wistar and spontaneously hypertensive rats.Naunyn Schmiedebergs Arch Pharmacol1986https://conductscience.org/library/papers/3821925PubMed
13512935Age-dependent alteration in the response of isolated rabbit basilar arteries to vasoactive agents.J Pharmacol Exp Ther1979https://conductscience.org/library/papers/512935PubMed

Download CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
2081137The role of serotonin in cardiovascular diseases and their treatment.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2081137PubMed
2079001Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.Drugs1990https://conductscience.org/library/papers/2079001PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2467792

GET https://conductscience.org/api/papers/v1/2467792/authors